Physician profile
Gregory James Zeiders
NPI 1801868211
$20,080.39
in general payments reported to CMS, 2019-2025
17 companies · $3,478 in 2025
The $3,478 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,658 · 2020: $20.67 · 2021: $2,076 · 2022: $4,247 · 2023: $1,983 · 2024: $1,618 · 2025: $3,478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,851 · Food and Beverage: $2,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,851.33 |
| Food and Beverage | $2,227.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $12,527.67 | 2019-2025 | |
| Pylant Medical | $4,819.98 | 2019-2025 | |
| Stryker Corporation | $2,081.90 | 2019-2025 | Mako, Triathlon |
| Omnilife Science, INC | $119.66 | 2025 | |
| Bone Support INC. | $115.78 | 2019 | |
| Catalyst Orthoscience | $93.47 | 2025 | |
| Merck Sharp & Dohme LLC | $61.78 | 2021-2025 | Bridion |
| P Bar Medical LLC | $55.11 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $42.63 | 2023 | Seglentis |
| Bioventus LLC | $41.08 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $20.67 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $20.64 | 2025 | Exparel, Zilretta, Iovera |
| Organogenesis INC. | $18.94 | 2019 | |
| Acera Surgical, INC. | $17.27 | 2022 | |
| Ermi LLC | $16.87 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $14.66 | 2019 | |
| Breg, INC | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Zeiders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.